Aspiration of normal or asymptomatic pathological joints for diagnosis and research: Indications, technique and success rate

Annals of the Rheumatic Diseases

Volumn 68, Issue 1, 2009, Pages 3-7

  Pascual, E ^a   Doherty, M ^b,c  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PYROPHOSPHATE; URATE; URIC ACID;

ARTHRITIS; CHONDROCALCINOSIS; GOUT; HUMAN; JOINT ASPIRATION; KNEE; METATARSOPHALANGEAL JOINT; MONITORING; NONHUMAN; OSTEOARTHRITIS; PATELLA; PRIORITY JOURNAL; PSEUDOGOUT; REVIEW; SYNOVIAL FLUID; SYNOVITIS;

ARTHRITIS; BIOPSY, NEEDLE; CALCIUM PYROPHOSPHATE; CASE-CONTROL STUDIES; CRYSTALLIZATION; GOUT; HUMANS; JOINT DISEASES; SYNOVIAL FLUID; URIC ACID;

EID: 58349097895     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.088328     Document Type: Review

References (35)

1. McCarty DJ, Hollander JL. Identification of urate crystals in gouty synovial fluid. Ann Intern Med 1961; 54:452-60.
2. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu T-F. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20:895-900.
3. Seegmeiller JE, Howell FIR, Malawista SE. The inflammatory reaction to sodium urate: its possible relationship to the genesis of acute gouty arthritis. JAMA 1962; 180:469-75.
4. Faires JS, McCarty DJ. Acute synovitis in normal joints of man and dog produced by injection of microcrystalline sodium urate, calcium oxalate and corticosteroid esters. Arthritis Rheum 1962; 5:295-6.
5. Faires JS, McCarty DJ. Acute arthritis in man and dog after intrasynovial injection of sodium urate crystals. Lancet 1962; 2:682.
6. McCarty DJ. Crystal induced inflammation and its treatment. In McCarty DJ, ed. Arthritis and allied conditions, 10th edn. Philadelphia: Lea & Febiger, 1985:1494-514.
7. Pascual E, Jovaní V. A quantitative study of the phagocytosis of urate crystals in the synovial fluid of asymptomatic joints of patients with gout. Br J Rheumatol 1995; 34:724-6.
8. Weinberger A, Schumacher HR, Agudelo CA. Urate crystals in asymptomatic metatarsophalangeal joints. Ann Intern Med 1979; 91:56-7.
9. Agudelo CA, Weinberger A, Schumacher HR, Turner R, Molina J. Definitive diagnosis of gout by identification of urate crystals in asymptomatic metatarsophalangeal joints. Arthritis Rheum 1979; 22:559-60.
10. Roualt T, Caldwell DS, Holmes EW. Aspiration of the asymptomatic metatarsophalangeal joint in gout patients and asymptomatic controls. Arthritis Rheum 1982; 25:209-12.
11. Gordon TP, Bertouch JV, Walsh BR, Brooks PM. Monosodium urate crystals in asymptomatic knee joints. J Rheumatol 1982; 9:967-9.
12. Bomalaski JS, Lluberas G, Schumacher HR. Monosodium urate crystals in the knee joints of patients with asymptomatic non-tophaceous gout. Arthritis Rheum 1986; 29:1480-4.
13. Pascual E. Persistence of monosodium urate crystals, and low grade inflammation, in the synovial fluid of untreated gout. Arthritis Rheum 1991; 34:141-5.
14. Pascual E, Batlle-Gualda E, Martínez A, Rosas J, Vela P. Synovial fluid analysis for diagnosis of intercritical gout. Ann Intern Med 1999; 131:756-9.
15. Li-Yu J, Clayburne G, Sieck M, Beutler A, Rull M, Eisner E, Schumacher HR Jr. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 2001; 28:577-80.
16. Pascual E, Sivera F. The time required for disappearance of urate crystals from synovial fluid after successful hypouricemic treatment relates to the duration of gout. Ann Rheum Dis 2007; 66:1056-8.
17. Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 51:321-5.
18. Beutler AM, Rull M, Schlesinger N, Baker DG, Hoffman Bl, Schumacher HR Jr. Treatment with allopurinol decreases the number of acute gout attacks despite persistently elevated serum uric acid levels. Clin Exp Rheumatol 2001, 19:595.
19. Pascual E, Castellano JA. Treatment with colchicine decreases the white cell counts in the synovial fluid of asymptomatic knees which contain monosodium urate crystals. J Rheumatol 1992; 19:600-3.
20. Zhang W, Doherty M, Pascual E, Bardin T, Barskove V, Conaghan P. et al. EULAR evidence based recommendations for gout, part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65:1301-11.
21. Schumacher HR Jr, Edwards LN, Pérez-Ruiz F, Becker M, Chen LX, Furst DE, et al. OMERACT 7 Special Interest Group: outcome measures for acute and chronic gout. J Rheumatol 2005: 32:2453-5.
22. Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, et al. EULAR Evidence based recommendations for gout, part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 25:1301-11.
23. Kohn NN, Hughes RE, McCarty DJ, Faires JS. The significance of calcium pyrophosphate crystals in the synovial fluid of arthritic patients: the "pseudogout syndrome". II. Identification of crystals. Ann Intern Med 1962; 56:738-45.
24. McCarty DJ, Phelps P, Pyenson J. Crystal-induced inflammation in canine joints. I. An experimental model with quantification of the host response. J Exp Med 1966; 124:99-114.
25. Bennett RM, Lehr JR, McCarty DJ. Crystal shedding and acute pseudogout: an hypothesis based on a therapeutic failure. Arthritis Rheum 1976; 19:93-7.
26. Martínez Sanchis A, Pascual E. Intracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy. Ann Rheum Dis 2005; 64:1769-72.
27. Pattrick M, Hamilton E, Hornby J, Doherty M. Synovial fluid pyrophosphate and nucleoside triphosphate pyrophosphatase: comparison between normal and diseased and between inflamed and non-inflamed joints. Ann Rheum Dis 1991; 50:214-8.
28. Doherty M, Dieppe PA, Watt I. Low incidence of calcium pyrophosphate dihydrate crystal deposition in rheumatoid arthritis with modification of radiographic features in coexistent disease. Arthritis Rheum 1984; 27:1002-9.
29. Neame RL, Zhang W, Deighton C, Doherty M, Doherty S, Lanyon P, et al. Distribution of radiographic osteoarthritis between right and left hands, hips and knees. Arthritis Rheum 2004; 50:1487-94.
30. Sivera F, Aragón R, Pascual E. First metatarsophalangeal joint aspiration using a 29- gauge needle. Ann Rheum Dis 2007; 67:273-5.
31. FitzGerald O, Soden M, Yanni G, Robinson R, Bresnihan B. Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. Ann Rheum Dis 1991; 50:792-6.
32. Wakefield RJ, Green MJ, Marzo-Ortega H, Conaghan PG, Gibbon WW, McGonagle D, et al. Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum Dis 2004; 63:382-5.
33. Pascual E. Analysis of synovial fluid from healthy knees. Comparison with fluid from asymptomatic knees in RA, SLE and gout. Br J Rheumatol 1992, 31 (Suppl 2):219.
34. Courtney P, Doherty M. Joint aspiration and injection. Best Pract Res Clin Rheumatol (Bailliere) 2005; 19:345-69.
35. Pascual E, Jovani V. Synovial fluid analysis. Best Pract Res Clin Rheumatol (Bailliere) 2005; 19:371-86.